GLP-1 drugs are driving higher sales for Eli Lilly and Novo Nordisk
· Global News
Sales of Mounjaro, Eli Lilly’s diabetes drug, rose 91 per cent in the second quarter of the year to US$9.94 billion, well above analysts' expectations.
Visit newssport.cv for more information.